I see the CKD and Dementia trials being 18 mths is all,... and at the same time do the CV trial bolt on.

But whatever we see, I just want to see a BP attached to the PR,... whether it be a Buy-Out or a Partnership,.. I just want top see a big name attached to us and monies involved. That will change our price, and if not a buy out allow us to get on the Nasdaq.

Then the story will finally start to unfold to the investors around the world what epigenetics can do and how far ahead of the others we are.